EPHA2 and osteosarcoma: It will be interesting to determine if deletion of one or more ephrin‐A ligands in the host bone microenvironment affects osteolysis induced by EphA2‐overexpressing tumor cells, especially because ephrin‐A1 expression in normal bone has been reported, as well as elevated ephrin‐A1 expression in human osteosarcomas.54